Company Description

Myris Therapeutics, formerly BioHybrid Solutions, is a privately held life sciences biotech company with proprietary technology to enable ultra-high DAR ADCs by integrating traditional ADC engineering with next-generation polymer chemistry. Using their innovative platform technology, Myris is developing a pipeline of novel therapeutics for oncology.